A detailed history of Hsbc Holdings PLC transactions in Organon & Co. stock. As of the latest transaction made, Hsbc Holdings PLC holds 12,700 shares of OGN stock, worth $243,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,700
Previous 60,163 78.89%
Holding current value
$243,586
Previous $1.13 Million 76.83%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $828,229 - $1.04 Million
-47,463 Reduced 78.89%
12,700 $262,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $13,724 - $18,724
996 Added 1.68%
60,163 $1.13 Million
Q4 2023

Feb 12, 2024

SELL
$10.95 - $17.32 $1.73 Million - $2.73 Million
-157,536 Reduced 72.7%
59,167 $853,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $860,456 - $1.23 Million
-51,866 Reduced 19.31%
216,703 $3.76 Million
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $300,669 - $384,301
15,603 Added 6.17%
268,569 $5.59 Million
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $819,186 - $1.23 Million
-38,244 Reduced 13.13%
252,966 $5.95 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $3.41 Million - $4.19 Million
146,318 Added 100.98%
291,210 $8.14 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $178,986 - $261,978
-7,649 Reduced 5.01%
144,892 $3.43 Million
Q2 2022

Aug 11, 2022

BUY
$31.66 - $38.9 $133,383 - $163,885
4,213 Added 2.84%
152,541 $5.25 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $361,563 - $467,360
11,874 Added 8.7%
148,328 $5.27 Million
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $4.16 Million - $5.39 Million
-145,243 Reduced 51.56%
136,454 $4.16 Million
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $451,981 - $562,648
15,787 Added 5.94%
281,697 $9.43 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $7.57 Million - $10.1 Million
265,910 New
265,910 $8.05 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.88B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.